856 Ind. Admin. Code 2-2-4

Current through September 4, 2024
Section 856 IAC 2-2-4 - Schedule III

Authority: IC 35-48-3-1

Affected: IC 35-48-2-8

Sec. 4.

(a) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.
(b) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 1308.32, and any other drug of the quantitative composition shown in that list for those drugs or that is the same, except that it contains a lesser quantity of controlled substances ..................................................

. 1405

(2) Benzphetamine ..........................................................................

1228

(3) Chlorphentermine ........................................................................

1645

(4) Clortermine .............................................................................

1647

(5) Mazindol ...............................................................................

1605

(6) Phendimetrazine .........................................................................

1615

(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system:
(1) Any compound, mixture, or preparation containing:

(A) Amobarbital ........................................................................

2125

(B) Secobarbital .........................................................................

2315

(C) Pentobarbital ........................................................................

2270

or any salt thereof and one (1) or more other active medicinal ingredient that are not listed in any schedule.

(2) Any suppository dosage form containing:

(A) Amobarbital ........................................................................

2125

(B) Secobarbital .........................................................................

2315

(C) Pentobarbital ........................................................................

2270

or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.

(3) Any substance that contains any quantity of a derivative of barbituric acid or any salt thereof ..............

2100

(4) Chlorhexadol .............................................................................

2510

(5) Ketamine, its salts, isomers, and salts of isomers .................................................

Some other names for ketamine: (-2(2-chlorophenyl) -2- (methylamino) - cyclohexanone

7285

(6) Lysergic acid .............................................................................

7300

(7) Lysergic acid amide ........................................................................

7310

(8) Methyprylon .............................................................................

2575

(9) Sulfondiethylmethane ......................................................................

2600

(10) Sulfonethylmethane .......................................................................

2605

(11) Sulfonmethane ...........................................................................

2610

(d) Nalorphine (a narcotic drug) .................................................................

9400

(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:
(1) Not more than one and eight-tenths (1.8) grams of codeine, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium ......... 9803
(2) Not more than one and eight-tenths (1.8) grams of codeine, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amo9u8n0ts4
(3) Not more than three hundred (300) milligrams of dihydrocodeinone, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium. . . 9805
(4) Not more than three hundred (300) milligrams of dihydrocodeinone, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients, in recognized therapeutic amounts .................................................................................... 9806
(5) Not more than one and eight-tenths (1.8) grams of dihydrocodeine, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts....................................................................................9807
(6) Not more than three hundred (300) milligrams of ethylmorphine, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts....................................................................................9808
(7) Not more than five hundred (500) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams or not more than twenty-five (25) milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts.................................................................9809
(8) Not more than fifty (50) milligrams of morphine, per one hundred (100) milliliters or per one hundred (100) grams with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts..........................9810
(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of anabolic steroids, including its salts, isomers, and salts of isomers whenever the existence of such salts of isomers is possible within the specific chemical designation................................................4000
(g) For hallucinogenic substances, dronabinol (synthetic) in sesame oil and encapsulated in a Zsoft gelatin capsule in a United States Food and Drug Administration-approved drug product.................................................7369

(Some other names for dronabinol: (6aR-trans) - 6a, 7, 8, 10a - tetrahydro-6,6,9 - trimethyl - 3-pentyl- 6H - dibenzo[b,d]pyrano-1-ol, or (1) [ALPHA]9 - (trans) - tetrahydrocan-nabinol.)

856 IAC 2-2-4

Indiana Board of Pharmacy; Reg 28, Ch II, Sec 2.13; filed Jul 9, 1974, 9:29 a.m.: Unpublished; filed Jun 9, 1977, 8:55 a.m.: Unpublished; filed May 26, 2000, 8:52 a.m.: 23 IR 2503; readopted filed Nov 14, 2001, 2:45 p.m.: 25 IR 1341; readopted filed Oct 4, 2007, 3:33 p.m.: 20071031-IR-856070060RFA; readopted filed November 25, 2013, 9:24 a.m.: 20131225-IR-856130308RFA
Readopted filed 2/15/2024, 1:16 p.m.: 20240313-IR-856230795RFA